FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

348445008: Product containing precisely scopolamine hydrobromide 150 microgram/1 each conventional release oral tablet (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3700063017 Hyoscine hydrobromide 150 microgram oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3700064011 Product containing precisely scopolamine hydrobromide 150 microgram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3700066013 Scopolamine hydrobromide 150 microgram oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Hyoscine hydrobromide 150 microgram oral tablet Is a Scopolamine hydrobromide false Inferred relationship Some
Hyoscine hydrobromide 150 microgram oral tablet Is a Hyoscine false Inferred relationship Some
Hyoscine hydrobromide 150 microgram oral tablet Has active ingredient Scopolamine (substance) false Inferred relationship Some
Hyoscine hydrobromide 150 microgram oral tablet Has manufactured dose form Tablet false Inferred relationship Some
Hyoscine hydrobromide 150 microgram oral tablet Is a Hyoscine hydrobromide false Inferred relationship Some
Hyoscine hydrobromide 150 microgram oral tablet Has active ingredient Scopolamine hydrobromide (substance) false Inferred relationship Some
Hyoscine hydrobromide 150 microgram oral tablet Is a Scopolamine hydrobromide false Inferred relationship Some
Hyoscine hydrobromide 150 microgram oral tablet Has manufactured dose form Oral tablet true Inferred relationship Some
Hyoscine hydrobromide 150 microgram oral tablet Is a Hyoscine-containing product in oral dose form false Inferred relationship Some
Hyoscine hydrobromide 150 microgram oral tablet Has active ingredient Scopolamine hydrobromide (substance) false Inferred relationship Some 1
Hyoscine hydrobromide 150 microgram oral tablet Has basis of strength substance (attribute) Scopolamine hydrobromide (substance) true Inferred relationship Some 1
Hyoscine hydrobromide 150 microgram oral tablet Has presentation strength numerator value 150 false Inferred relationship Some 1
Hyoscine hydrobromide 150 microgram oral tablet Has presentation strength numerator unit mcg true Inferred relationship Some 1
Hyoscine hydrobromide 150 microgram oral tablet Has presentation strength denominator value 1 false Inferred relationship Some 1
Hyoscine hydrobromide 150 microgram oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Some 1
Hyoscine hydrobromide 150 microgram oral tablet Has presentation strength numerator value 0.15 false Inferred relationship Some 1
Hyoscine hydrobromide 150 microgram oral tablet Has presentation strength numerator unit mg false Inferred relationship Some 1
Hyoscine hydrobromide 150 microgram oral tablet Has unit of presentation Tablet (unit of presentation) true Inferred relationship Some
Hyoscine hydrobromide 150 microgram oral tablet Has precise active ingredient Scopolamine hydrobromide (substance) true Inferred relationship Some 1
Hyoscine hydrobromide 150 microgram oral tablet Count of base of active ingredient 1 false Inferred relationship Some
Hyoscine hydrobromide 150 microgram oral tablet Is a Hyoscine only product in oral dose form true Inferred relationship Some
Hyoscine hydrobromide 150 microgram oral tablet Plays role Antiemetic therapeutic role (role) false Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start